Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Lung Neoplasms × icotinib × Clear all

Phase

Phase 2 4 Phase EARLY_PHASE1 1 Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 6 Brain Neoplasms 2 Non-squamous Non-small Cell Lung Cancer 1 Lung Neoplasms 1 Adenocarcinoma 1

Interventions

Cisplatin 50 Carboplatin 49 Radiotherapy 33 Paclitaxel 28 Docetaxel 26 Pemetrexed 24 Gemcitabine 24 Etoposide 21 pembrolizumab 18 Vinorelbine 16 Drug Therapy 10 Radiosurgery 9 Magnetic Resonance Spectroscopy 9 Erlotinib Hydrochloride 9 Specimen Handling 8 Nivolumab 8 durvalumab 7 Gefitinib 6 Cyclophosphamide 6 Bevacizumab 6 Topotecan 5 Surgical Procedures, Operative 5 Standard of Care 5 Platinum 5 Dexamethasone 5 atezolizumab 4 Vinblastine 4 Immunoglobulin G 4 Ifosfamide 4 Doxorubicin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01996098 2024-09-05

ICTAN

Sun Yat-sen University

Phase 3 Terminated

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡